Skip to main content

Table 3 Base-case input parameters used in the model

From: Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Parameter Values
Vaccine uptake, both sexes  
  Cumulative percentage of vaccine uptake (first dose) among 12-year olds 70%
Vaccine adherence (probability of second and third dose), both sexes  
  Percentage of individuals receiving the second dose given first dose 79.7%
  Percentage of individuals receiving the third dose given second dose 63.5%
Duration of protection (years) lifelong
  1. HPV, human papillomavirus. Values were derived from [17].